|
Nobivac KC
|
-
|
V/NRP/02/1487
|
Intervet International B.V., Nīderlande
|
QI07AF
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
nasal drops, lyophilisate and solvent for suspension
|
| International name (active substance): |
Live Bordetella bronchiseptica,Live Canine parainfluenza virus (CPi) strain Cornell
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
18-Aug-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Mar-2026)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Mar-2026)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (23-Mar-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1487-01 |
|
5 |
Stikla flakons, 1 deva |
[PDF]
[PDF]
[PDF]
|
| V/NRP/02/1487-04 |
|
25 |
Stikla flakons, 1 deva |
-
|
|
|
Ficoxil
|
57 mg
|
V/DCP/21/0047
|
Industrial Veterinaria, S.A., Spānija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0047-01 |
57 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0047-02 |
57 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0047-03 |
57 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0047-04 |
57 mg |
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0047-05 |
57 mg |
18 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
|
|
Ficoxil
|
227 mg
|
V/DCP/21/0048
|
Industrial Veterinaria, S.A., Spānija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0048-01 |
227 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0048-02 |
227 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0048-03 |
227 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0048-04 |
227 mg |
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/21/0048-05 |
227 mg |
18 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
|
|
Robexera
|
5 mg
|
V/DCP/23/0027
|
KRKA, d.d., Novo mesto, Slovēnija
|
QM01AH91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0027-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0027-02 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0027-03 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Robexera
|
10 mg
|
V/DCP/23/0028
|
KRKA, d.d., Novo mesto, Slovēnija
|
QM01AH91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0028-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0028-02 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0028-03 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Robexera
|
20 mg
|
V/DCP/23/0029
|
KRKA, d.d., Novo mesto, Slovēnija
|
QM01AH91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0029-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0029-02 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0029-03 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Robexera
|
40 mg
|
V/DCP/23/0030
|
KRKA, d.d., Novo mesto, Slovēnija
|
QM01AH91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0030-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0030-02 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0030-03 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
PROPALIN
|
50 mg/ml
|
V/MRP/05/1639
|
Vetoquinol S.A., Francija
|
QG04BX91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/05/1639-01 |
40 mg/ml |
1 |
ABPE pudele, 30 ml |
-
|
| V/MRP/05/1639-02 |
40 mg/ml |
1 |
ABPE pudele, 100 ml |
-
|
|
|
Avishield IB H120
|
-
|
V/DCP/18/0002
|
Izo S.r.l., Itālija
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension/use in drinking water
|
| International name (active substance): |
Attenuated live virus of avian infectious bronchitis, Massachusetts serotype, strain H-120
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (25-May-2026)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (25-May-2026)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (25-May-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0002-01 |
|
10 |
Stikla flakons, 1000 deva |
-
|
| V/DCP/18/0002-02 |
|
10 |
Stikla flakons, 2500 deva |
-
|
| V/DCP/18/0002-03 |
|
10 |
Stikla flakons, 5000 deva |
-
|
|
|
Avishield IB GI-13
|
-
|
V/DCP/20/0014
|
Izo S.r.l., Itālija
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0014-01 |
|
10 |
Stikla flakons, 1000 deva |
-
|
| V/DCP/20/0014-02 |
|
10 |
Stikla flakons, 2500 deva |
-
|
| V/DCP/20/0014-03 |
|
10 |
Stikla flakons, 5000 deva |
-
|
|
|
Cobactan 2,5%
|
25 mg/ml
|
V/NRP/05/1275
|
Intervet International B.V., Nīderlande
|
QJ01DE90
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/05/1275-01 |
25 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/05/1275-02 |
25 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Bovilis Bovipast RSP
|
-
|
V/NRP/05/1660
|
Intervet International B.V., Nīderlande
|
QI02AL04
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bovine respiratory sincitial (BRS) virus, strain EV908, Inactivated parainfluenza-3 virus, str. SF-4 Reisinger, Inactivated Mannheimia (Pasteurella) haemolytica A1, strain M4/1
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
08-Jun-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/05/1660-01 |
|
1 |
Stikla flakons, 50 ml |
-
|
|
|
Bovilis Rotavec Corona
|
-
|
V/MRP/08/0002
|
Intervet International B.V., Nīderlande
|
QI02AL01
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Bovine coronavirus, strain Mebus, Inactivated, Bovine rotavirus, strain UK-Compton, Inactivated, E. coli F5 (K99) adhesin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
09-Jul-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (13-Apr-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/08/0002-01 |
|
10 |
Stikla flakons, 2 ml |
-
|
| V/MRP/08/0002-02 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/MRP/08/0002-03 |
|
1 |
Stikla flakons, 40 ml |
-
|
| V/MRP/08/0002-04 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/MRP/08/0002-05 |
|
1 |
PET flakons, 10 ml |
-
|
| V/MRP/08/0002-06 |
|
1 |
PET flakons, 40 ml |
-
|
| V/MRP/08/0002-07 |
|
1 |
PET flakons, 100 ml |
-
|
|
|
Clorexivet 4%
|
40 mg/ml
|
V/DCP/26/0021
|
NEXTMUNE ITALY S.R.L., Itālija
|
QD08AC02
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/26/0021-01 |
|
1 |
ABPE pudele, 250 ml |
-
|
|
|
Pimocard
|
1.25 mg
|
V/MRP/15/0060
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0060-01 |
1,25 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0060-02 |
1,25 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0060-03 |
1,25 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
[JPG]
|
| V/MRP/15/0060-04 |
1,25 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0060-05 |
1,25 mg |
2 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0060-06 |
1,25 mg |
5 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0060-07 |
1,25 mg |
10 |
Al/Al blisteris, 10 tablete |
[JPG]
|
| V/MRP/15/0060-08 |
1,25 mg |
25 |
Al/Al blisteris, 10 tablete |
-
|
|
|
Pimocard
|
5 mg
|
V/MRP/15/0062
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0062-01 |
5 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0062-02 |
5 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0062-03 |
5 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
[JPG]
|
| V/MRP/15/0062-04 |
5 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0062-05 |
5 mg |
4 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0062-06 |
5 mg |
10 |
Al/Al blisteris, 5 tablete |
[JPG]
|
| V/MRP/15/0062-07 |
5 mg |
20 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0062-08 |
5 mg |
50 |
Al/Al blisteris, 5 tablete |
-
|
|
|
Pimocard
|
2.5 mg
|
V/MRP/15/0061
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0061-01 |
2,5 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-02 |
2,5 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-03 |
2,5 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-04 |
2,5 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-05 |
2,5 mg |
2 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0061-06 |
2,5 mg |
5 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0061-07 |
2,5 mg |
10 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0061-08 |
2,5 mg |
25 |
Al/Al blisteris, 10 tablete |
-
|
|
|
Pimocard
|
10 mg
|
V/MRP/15/0063
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0063-01 |
10 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-02 |
10 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-03 |
10 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-04 |
10 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-05 |
10 mg |
4 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0063-06 |
10 mg |
10 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0063-07 |
10 mg |
20 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0063-08 |
10 mg |
50 |
Al/Al blisteris, 5 tablete |
-
|
|
|
Metaphosol
|
200 mg/ml
|
V/NRP/14/0035
|
Alivira Animal Health Limited;, Īrija
|
QA12CX90
|
cattle; pigs; sheep; goats; horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/14/0035-01 |
200 mg/ml |
1 |
Stikla (tumša) flakons, 50 ml |
-
|
| V/NRP/14/0035-02 |
200 mg/ml |
1 |
Stikla (tumša) flakons, 100 ml |
-
|
| V/NRP/14/0035-03 |
200 mg/ml |
10 |
Stikla (tumša) flakons, 50 ml |
-
|
| V/NRP/14/0035-04 |
200 mg/ml |
12 |
Stikla (tumša) flakons, 100 ml |
-
|
|
|
ERYSIN SINGLE SHOT
|
-
|
V/NRP/00/1059
|
Bioveta, a.s., Čehija
|
QI09AB03
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/00/1059-01 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/00/1059-02 |
|
5 |
Stikla flakons, 20 ml |
-
|
| V/NRP/00/1059-03 |
|
1 |
Plastikāta flakons, 100 ml |
-
|
|